Lexaria Bioscience (LEXX) Net Income Growth (3y) (2020 - 2026)
Lexaria Bioscience (LEXX) Net Income Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
30.59% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
19.97% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.49 Mn |
1.97 Mn |
20,000.00 |
-3.15% |
| Date | Value |
|---|
| Feb 28, 2026 |
-3.15% |
| Nov 30, 2025 |
2.42% |
| Aug 31, 2025 |
-53.09% |
| May 31, 2025 |
-15.75% |
| Feb 28, 2025 |
-23.83% |
| Nov 30, 2024 |
-10.33% |
| Feb 29, 2024 |
-198.96% |
| Nov 30, 2023 |
-623.85% |
| Aug 31, 2023 |
-284.42% |
| May 31, 2023 |
-399.23% |
| Feb 28, 2023 |
-182.82% |
| Nov 30, 2022 |
-227.17% |
| Aug 31, 2022 |
12.46% |
| May 31, 2022 |
-26.74% |
| Feb 28, 2022 |
-7.90% |
| Nov 30, 2021 |
-41.89% |
| Feb 28, 2021 |
73.73% |
| Nov 30, 2020 |
26.10% |
| Aug 31, 2020 |
69.91% |
| May 31, 2020 |
27.18% |
